Insider · CIK 0001508890

Wee Wendy

Reports to the SEC for 2 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001508890

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-08-27	Kindred Biosciences, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−78.6K sh	$9.25	−$727K	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−32.5K sh	$2.29	−$74.4K	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−10K sh	$6.00	−$60K	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−75K sh	$2.85	−$214K	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−50K sh	$2.15	−$108K	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−75K sh	$0.50	−$37.5K	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−100K sh	—	—	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−50K sh	—	—	0
2021-08-27	Kindred Biosciences, Inc.Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−83.5K sh	$4.81	−$402K	0
2021-01-23	Kindred Biosciences, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,385 sh	$4.93	−$16.7K	49,039
2021-01-22	Kindred Biosciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,500 sh	—	—	56,486
2021-01-22	Kindred Biosciences, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−4,062 sh	$4.93	−$20K	52,424
2021-01-22	Kindred Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,500 sh	—	—	7,500
2021-01-20	Kindred Biosciences, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+83.5K sh	—	—	83,500
2021-01-17	Kindred Biosciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,250 sh	—	—	52,371
2021-01-17	Kindred Biosciences, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−3,385 sh	$4.95	−$16.8K	48,968
2021-01-17	Kindred Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−6,250 sh	—	—	18,750
2020-01-23	Kindred Biosciences, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−2,145 sh	$9.66	−$20.7K	44,121
2020-01-22	Kindred Biosciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,500 sh	—	—	48,726
2020-01-22	Kindred Biosciences, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−2,460 sh	$9.88	−$24.3K	46,266
2020-01-22	Kindred Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,500 sh	—	—	15,000
2020-01-17	Kindred Biosciences, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2020-01-17	Kindred Biosciences, Inc.Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+25K sh	—	—	25,000
2019-02-01	Kindred Biosciences, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2019-01-23	Kindred Biosciences, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−2,138 sh	$9.95	−$21.3K	38,827
2019-01-22	Kindred Biosciences, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,500 sh	—	—	43,733
2019-01-22	Kindred Biosciences, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−2,768 sh	$10.12	−$28K	40,965
2019-01-22	Kindred Biosciences, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,500 sh	—	—	22,500
2018-01-23	Kindred Biosciences, Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−2,282 sh	$9.15	−$20.9K	30,718
2018-01-22	Kindred Biosciences, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+75K sh	—	—	75,000
2018-01-22	Kindred Biosciences, Inc.Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+30K sh	—	—	30,000
2017-07-28	Kindred Biosciences, Inc.Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+50K sh	—	—	50,000
2011-05-25	MABVAX THERAPEUTICS HOLDINGS, INC.Non-Qualified Stock Option (right to buy)A Award	VP, Finance & Controller	AAward	+290K sh	—	—	290,000

Recent filings

Accepted (ET)
Aug 304
Wee Wendy0001250853-21-000091
SEC(opens sec.gov)
Jan 264
Wee Wendy0001250853-21-000023
SEC(opens sec.gov)
Jan 204
Wee Wendy0001250853-21-000013
SEC(opens sec.gov)
Jan 244
Wee Wendy0001250853-20-000039
SEC(opens sec.gov)

Companies

Address

3165 PORTER DRIVE

PALO ALTO, CA, 94304-1213